← Leaderboards

Aminah Jatoi

Mayo Clinic Coll Of Medicine, Rochester

Google Scholar ↗PubMed ↗ORCID ↗

$17,973,141

Attributed

$19,983,925

Total exposure

14

Grants

9

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY2005–25

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$19,983,925 · 14

By mechanism

K12$11,823,947 · 1

R01$4,640,308 · 3

R21$1,600,431 · 4

K24$872,935 · 1

K07$596,284 · 1

K23$352,292 · 1

Top collaborators

Most similar at Mayo Clinic Coll Of Medicine, Rochester

Same institution · by research overlap

Michael L Camilleri$18,731,842

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsResearch PersonnelProgramsPositioning AttributeCancer PatientClinical TrialsClinicComprehensive Cancer CenterBaseClinical ResearchCareerSymptomsNovel TherapeuticsInstitutionFundingAwardTranslational ResearchPrincipal InvestigatorPublishingAdverse EventOncologyMentorsLeadershipGrant

Grant awards (58)

Older Sexual Minority Patients with Serious Illness: Program-Building to Identify and Address Needs$149,071

K07 · FY2025 · AG · contact PI

Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic$782,520

K12 · FY2024 · CA · contact PI

Older Sexual and Gender Minority Patients with Serious Illness: Program-Building to Identify and Address Needs$149,071

K07 · FY2024 · AG · contact PI

Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic$674,416

K12 · FY2023 · CA · contact PI

Older Sexual and Gender Minority Patients with Serious Illness: Program-Building to Identify and Address Needs$149,071

K07 · FY2023 · AG · contact PI

Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients$1

R01 · FY2023 · CA · contact PI

Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic$810,000

K12 · FY2022 · CA · contact PI

Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients$353,510

R01 · FY2022 · CA · contact PI

Older Sexual and Gender Minority Patients with Serious Illness: Program-Building to Identify and Address Needs$149,071

K07 · FY2022 · AG · contact PI

Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic$689,677

K12 · FY2021 · CA · contact PI

Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients$365,812

R01 · FY2021 · CA · contact PI

Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic$780,398

K12 · FY2020 · CA · contact PI

Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$466,544

R01 · FY2020 · CA · contact PI

Cancer Research Career Enhancement and Related Activities$61,370

P30 · FY2020 · CA · contact PI

Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic$791,954

K12 · FY2019 · CA · contact PI

Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$452,547

R01 · FY2019 · CA · contact PI

Cancer Research Career Enhancement and Related Activities$34,709

P30 · FY2019 · CA · contact PI

Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients$1

R01 · FY2019 · CA · contact PI

Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic$746,756

K12 · FY2018 · CA · contact PI

Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients$377,127

R01 · FY2018 · CA · contact PI

Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$1

R01 · FY2018 · CA · contact PI

Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic$810,000

K12 · FY2017 · CA · contact PI

Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$466,544

R01 · FY2017 · CA · contact PI

Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients$385,278

R01 · FY2017 · CA · contact PI

Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic$757,020

K12 · FY2016 · CA · contact PI

Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$466,544

R01 · FY2016 · CA · contact PI

Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic$1,124,848

K12 · FY2015 · CA · contact PI

Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$466,544

R01 · FY2015 · CA · contact PI

The pathophysiology and palliation of the paclitaxel-induced acute pain syndrome$172,095

R21 · FY2015 · CA · contact PI

Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic$899,782

K12 · FY2014 · CA · contact PI

The pathophysiology and palliation of the paclitaxel-induced acute pain syndrome$192,765

R21 · FY2014 · CA · contact PI

Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic$897,597

K12 · FY2013 · CA · contact PI

Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic$924,979

K12 · FY2012 · CA · contact PI

Mentoring and Research in Cancer Palliative Care$194,903

K24 · FY2012 · CA · contact PI

Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic$1,134,000

K12 · FY2011 · CA · contact PI

Wine for Cancer-Associated Anorexia$203,881

R01 · FY2011 · CA · contact PI

Mentoring and Research in Cancer Palliative Care$194,903

K24 · FY2011 · CA · contact PI

Wine for Cancer-Associated Anorexia$211,540

R01 · FY2010 · CA · contact PI

Mentoring and Research in Cancer Palliative Care$194,903

K24 · FY2010 · CA · contact PI

Wine for Cancer-Associated Anorexia$211,540

R01 · FY2009 · CA · contact PI

Rash from EGFR Inhibitors: Characterization & Palliation of a Symptom Cluster$169,988

R21 · FY2009 · CA · contact PI

Mentoring and Research in Cancer Palliative Care$96,784

K24 · FY2009 · CA · contact PI

Rash from EGFR Inhibitors: Characterization & Palliation of a Symptom Cluster$203,985

R21 · FY2008 · CA · contact PI

Mentoring and Research in Cancer Palliative Care$191,442

K24 · FY2008 · CA · contact PI

Wine for Cancer-Associated Anorexia$1,354

R01 · FY2008 · CA · contact PI

Wine for Cancer-Associated Anorexia$211,540

R01 · FY2007 · CA · contact PI

MC01C7, PHASE I STUDY OF INHALED NEUROPEPTIDE Y FOR CANCER ASSOCIATED ANOREXIA$1,185

M01 · FY2005 · RR

Creatine: Is It a Body Builder for Cancer Patients?$182,500

R21 · FY2004 · CA

Mechanisms and Therapeutics in Cancer Anorexia/Cachexia$117,701

K23 · FY2004 · CA

Phase I Study--Inhaled Neuropeptide Y for Canc Anorexia$464

M01 · FY2004 · RR

Neuropeptide Y for Cancer-Associated Anorexia$243,348

R21 · FY2003 · CA

Creatine: Is It a Body Builder for Cancer Patients?$182,500

R21 · FY2003 · CA

Mechanisms and Therapeutics in Cancer Anorexia/Cachexia$117,427

K23 · FY2003 · CA

Neuropeptide Y for Cancer-Associated Anorexia$253,250

R21 · FY2002 · CA

Mechanisms and Therapeutics in Cancer Anorexia/Cachexia$117,164

K23 · FY2002 · CA

DIETARY DETERMINANTS OF DISEASE FREE SURVIVAL IN NON-SMALL CELL LUNG CANCER$0

M01 · FY2002 · RR

DIETARY DETERMINANTS OF DISEASE FREE SURVIVAL IN NON-SMALL CELL LUNG CANCER$0

M01 · FY2001 · RR

DIETARY DETERMINANTS OF DISEASE FREE SURVIVAL IN NON-SMALL CELL LUNG CANCER$0

M01 · FY2000 · RR